These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3510601)

  • 1. Imipramine and chlordiazepoxide in depressive and anxiety disorders. I. Efficacy in depressed outpatients.
    Lipman RS; Covi L; Rickels K; McNair DM; Downing R; Kahn RJ; Lasseter VK; Faden V
    Arch Gen Psychiatry; 1986 Jan; 43(1):68-77. PubMed ID: 3510601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imipramine and chlordiazepoxide in depressive and anxiety disorders. II. Efficacy in anxious outpatients.
    Kahn RJ; McNair DM; Lipman RS; Covi L; Rickels K; Downing R; Fisher S; Frankenthaler LM
    Arch Gen Psychiatry; 1986 Jan; 43(1):79-85. PubMed ID: 3510602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of phenelzine and imipramine in depressed inpatients.
    Davidson JR; McLeod MN; Turnbull CD; Miller RD
    J Clin Psychiatry; 1981 Oct; 42(10):395-7. PubMed ID: 7026542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lofepramine and imipramine in unipolar depressed outpatients. A placebo controlled study.
    Rickels K; Weise CC; Zal HM; Csanalosi I; Werblowsky J
    Acta Psychiatr Scand; 1982 Aug; 66(2):109-20. PubMed ID: 6753501
    [No Abstract]   [Full Text] [Related]  

  • 5. A double-blind comparison of fluoxetine, imipramine and placebo in outpatients with major depression.
    Feighner JP; Boyer WF; Merideth CH; Hendrickson GG
    Int Clin Psychopharmacol; 1989 Apr; 4(2):127-34. PubMed ID: 2663975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alprazolam, diazepam, imipramine, and placebo in outpatients with major depression.
    Rickels K; Chung HR; Csanalosi IB; Hurowitz AM; London J; Wiseman K; Kaplan M; Amsterdam JD
    Arch Gen Psychiatry; 1987 Oct; 44(10):862-6. PubMed ID: 3310952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amoxapine and imipramine in the treatment of depressed outpatients: a controlled study.
    Rickels K; Case WG; Werblowsky J; Csanalosi I; Schless A; Weise CC
    Am J Psychiatry; 1981 Jan; 138(1):20-4. PubMed ID: 7446776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind comparison of paroxetine, imipramine and placebo in depressed outpatients.
    Feighner JP
    Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 4():31-5. PubMed ID: 1431008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind comparative evaluation of the efficacy and safety of nomifensine, imipramine, and placebo in depressed geriatric outpatients.
    Merideth CH; Feighner JP; Hendrickson G
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):73-7. PubMed ID: 6370981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of imipramine and chlordiazepoxide in depressive and anxiety disorders questioned.
    Welner J
    Arch Gen Psychiatry; 1987 Jan; 44(1):97-8. PubMed ID: 3800590
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative efficacy of alprazolam, imipramine, and placebo administered once a day in treating depressed patients.
    Mendels J; Schless AP
    J Clin Psychiatry; 1986 Jul; 47(7):357-61. PubMed ID: 2873131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter double-blind comparison of nomifensine and imipramine for efficacy and safety in depressed outpatients.
    Bremner JD; Abrahams LM; Crupie JE; McCawley A; Proctor RC; Sathananthan GL
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):56-9. PubMed ID: 6370976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluvoxamine, imipramine, and placebo in the treatment of depressed outpatients: effects on depression.
    Lydiard RB; Laird LK; Morton WA; Steele TE; Kellner C; Laraia MT; Ballenger JC
    Psychopharmacol Bull; 1989; 25(1):68-70. PubMed ID: 2505304
    [No Abstract]   [Full Text] [Related]  

  • 14. Withdrawal reactions to diazepam in combined imipramine/diazepam treatment of primary nonagitated depressed outpatients.
    Feet PO; Larsen S; Lillevold PE; Robak OH
    Acta Psychiatr Scand; 1988 Sep; 78(3):341-7. PubMed ID: 3057815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A preliminary study on the efficacy of sertraline and imipramine on anger attacks in atypical depression and dysthymia.
    Fava M; Nierenberg AA; Quitkin FM; Zisook S; Pearlstein T; Stone A; Rosenbaum JF
    Psychopharmacol Bull; 1997; 33(1):101-3. PubMed ID: 9133758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoxetine in depressed patients: a comparison with imipramine.
    Bremner JD
    J Clin Psychiatry; 1984 Oct; 45(10):414-9. PubMed ID: 6384203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant specificity in atypical depression.
    Liebowitz MR; Quitkin FM; Stewart JW; McGrath PJ; Harrison WM; Markowitz JS; Rabkin JG; Tricamo E; Goetz DM; Klein DF
    Arch Gen Psychiatry; 1988 Feb; 45(2):129-37. PubMed ID: 3276282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder.
    Stark P; Hardison CD
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):53-8. PubMed ID: 3882682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenelzine v imipramine in atypical depression. A preliminary report.
    Liebowitz MR; Quitkin FM; Stewart JW; McGrath PJ; Harrison W; Rabkin J; Tricamo E; Markowitz JS; Klein DF
    Arch Gen Psychiatry; 1984 Jul; 41(7):669-77. PubMed ID: 6375621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adinazolam, diazepam, imipramine, and placebo in major depressive disorder: a controlled study.
    Rickels K; London J; Fox I; Hassman H; Csanalosi I; Weise C
    Pharmacopsychiatry; 1991 Jul; 24(4):127-31. PubMed ID: 1754608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.